| Serial Number | 79272941 |
| Word Mark | BP BALKAN PHARMACEUTICALS |
| Filing Date | Tuesday, October 1, 2019 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, October 6, 2020 |
| Registration Number | 6166331 |
| Registration Date | Tuesday, October 6, 2020 |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, July 21, 2020 |
| Description of Mark | The mark consists of the letters "BP" with a vertical curved band between the letters, all in blue, to the left of a blue double helix design. Below the letters and design is the wording "BALKAN PHARMACEUTICALS" in blue letters. All on a white background. |
| Description of the Colors Claimed | Blue: all the verbal and figurative elements; white: background |
| Goods and Services | Pharmaceutical, medical and veterinary products, namely, products for treating digestive maladies and for affecting metabolism namely, antacids, antiulcerous preparations, antiflatulence preparations; antispastics, anticolinergics, antipropulsives; antivomitive and antinauseants, antidiarrheals; digestive aids, namely, food enzyme and dietary supplements; metabolic aids, namely, stanozolol, methandienone, mesterolone, oxandrolone and nandrolone; products for treating the liver, namely, lipotropics; products for treating disorders and illnesses of blood, haematopoetic organs- and the heparin group, namely, platelet antiaggregants; products for treating disorders and illnesses of the cardiovascular system and for providing heart therapy, namely, diuretics, peripherical vasodilators; blockers, namely, bisoprolol, pantoprazole, famotidine and naltrexone; products that act on the renin-angiotensin system, namely, ramipril, lizinopril, enalapril and captoprile; pharmaceuticals, namely, lipid lowering agents; genital-urinary system and sexual hormones, sexual and modulator hormones of the genital system, genital system medications; systemic hormonal preparations; antiinfectious products for systemic use, namely, ofloxacine, metronidazole, acyclovir, amoxaciline and furaciline; antineoplastic agents and immunomodulators; products for treating the skeletal muscle system, namely, antiinflammatory and antirheumatic non-steroids; products for treating the nervous system, namely, anesthetics, anticonvulsants, antiemetics, antiparkinson agents, CNS stimulants, muscle relaxants, narcotic analgesics, nonnarcotic analgesics, and sedatives; antiparasitics; products for treating the breathing pathway, namely, antiasthmatics, systemic antihistamines; sanitary products for medical use, namely, absorbent products for personal health care and hygiene, medical disinfectant liquids, wipes, sprays and soaps |
| Indication of Colors claimed | The color(s) white and blue is/are claimed as a feature of the mark. |
| NOT AVAILABLE | "BALKAN PHARMACEUTICALS" |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, December 2, 2019 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | EURO MAST INDUSTRIES S.R.L., societate comerciala |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 99 - Other |
| Address | RO |
| Party Name | EURO MAST INDUSTRIES S.R.L., societate comerciala |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | RO |
| Party Name | EURO MAST INDUSTRIES S.R.L., societate comerciala |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | RO |
| Event Date | Event Description |
| Monday, December 2, 2019 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, January 10, 2020 | NON-FINAL ACTION WRITTEN |
| Friday, January 10, 2020 | NON-FINAL ACTION WRITTEN |
| Saturday, January 11, 2020 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Thursday, November 28, 2019 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Friday, December 6, 2019 | APPLICATION FILING RECEIPT MAILED |
| Friday, January 3, 2020 | ASSIGNED TO EXAMINER |
| Saturday, February 22, 2020 | REFUSAL PROCESSED BY IB |
| Friday, April 24, 2020 | NON-FINAL ACTION E-MAILED |
| Wednesday, February 5, 2020 | REFUSAL PROCESSED BY MPU |
| Wednesday, February 5, 2020 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Thursday, March 26, 2020 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, March 26, 2020 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, March 26, 2020 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, April 24, 2020 | NON-FINAL ACTION WRITTEN |
| Friday, April 24, 2020 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, May 19, 2020 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, June 17, 2020 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, July 1, 2020 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Wednesday, July 15, 2020 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
| Wednesday, July 15, 2020 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Tuesday, July 21, 2020 | PUBLISHED FOR OPPOSITION |
| Tuesday, July 21, 2020 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Friday, July 31, 2020 | NOTIFICATION PROCESSED BY IB |
| Tuesday, October 6, 2020 | REGISTERED-PRINCIPAL REGISTER |
| Wednesday, January 6, 2021 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Monday, March 1, 2021 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| Monday, October 6, 2025 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED |
| Thursday, January 28, 2021 | GENERIC MADRID TRANSACTION SENT TO IB |
| Tuesday, May 19, 2020 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, May 20, 2020 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, January 28, 2021 | GENERIC MADRID TRANSACTION CREATED |